(NP (NP Abnormalities/NNS) (PP of/IN (NP (NP-COOD (NP p16/NN) ,/, (NP p15/NN) and/CC (NP CDK4/NN)) genes/NNS)) (PP in/IN (NP recurrent/JJ malignant/JJ astrocytomas/NNS)) ./.)
(S (NP-SBJ-38 (NP Abnormalities/NNS) (PP in/IN (NP (NP the/DT (NP-COOD (NP p16/NN) ,/, (NP p15/NN) and/CC (NP CDK4/NN)) genes/NNS) (SBAR (WHNP-39 that/WDT) (S (NP-SBJ *T*-39/-NONE-) (VP regulate/VBP (NP (NP transition/NN) (PP through/IN (NP (NP the/DT G1/NN phase/NN) (PP of/IN (NP the/DT cell/NN cycle/NN))))))))))) (VP have/VBP (VP been/VBN (VP implicated/VBN (NP *-38/-NONE-) (PP in/IN (NP (NP the/DT malignant/JJ progression/NN) (PP of/IN (NP astrocytomas/NNS))))))) ./.)
(S (NP-SBJ (NP The/DT results/NNS) (PP of/IN (NP the/DT present/JJ study/NN))) (VP demonstrate/VBP (SBAR that/IN (S (NP-SBJ (NP dysfunction/NN) (PP of/IN (NP these/DT genes/NNS))) (ADVP also/RB) (VP occurs/VBZ (PP-TMP during/IN (NP (NP recurrence/NN) (PP of/IN (NP (NP glial/JJ tumors/NNS) (SBAR (WHNP-40 that/WDT) (S (NP-SBJ *T*-40/-NONE-) (VP were/VBD (ADJP-PRD highly/RB malignant/JJ) (PP at/IN (NP first/JJ presentation/NN))))))))))))) ./.)
(S (NP-SBJ (NP Analysis/NN) (PP of/IN (NP (NP 10/CD matched/VBN pairs/NNS) (PP of/IN (NP-COOD (NP high/JJ grade/NN malignant/JJ astrocytomas/NNS) and/CC (NP their/PRP$ subsequent/JJ recurrences/NNS)))))) (VP identified/VBD (NP three/CD distinct/JJ groups/NNS)) ./.)
(S-COOD (S (NP-SBJ (NP The/DT (ADJP-COOD (ADJP primary/JJ) and/CC (ADJP recurrent/JJ)) tumors/NNS) (PP in/IN (NP Group/NN A/NN))) (VP did/VBD not/RB (VP show/VB (NP (NP structural/JJ alterations/NNS) (PP in/IN (NP the/DT (NP-COOD (NP p16/NN) ,/, (NP p15/NN) or/CC (NP CDK4/NN)) genes/NNS)))))) ,/, whereas/IN (S (NP-SBJ-41 (NP homozygous/JJ codeletion/NN) (PP of/IN (NP-COOD (NP p16/NN) and/CC (NP p15/NN)))) (VP was/VBD (VP observed/VBN (NP *-41/-NONE-) (PP in/IN (NP (NP (ADJP-COOD both/CC (ADJP primary/JJ) and/CC (ADJP recurrent/JJ)) tumors/NNS) (PP in/IN (NP Group/NN B/NN))))))) ./.)
(S (NP-SBJ (NP The/DT primary/JJ tumors/NNS) (PP in/IN (NP Group/NN C/NN))) (VP had/VBD (NP (NP a/DT normal/JJ profile/NN) (PP of/IN (NP-COOD (NP p16/NN) ,/, (NP p15/NN) and/CC (NP CDK4/NN)))) (PP at/IN (NP presentation/NN))) ./.)
(S (PP-TMP Upon/IN (NP recurrence/NN)) ,/, (ADVP however/RB) ,/, (NP-SBJ the/DT tumors/NNS) (VP sustained/VBD (NP-COOD either/CC (NP (NP deletion/NN) (PP of/IN (NP (NP p16/NN) (ADVP alone/RB)))) or/CC (NP (NP codeletion/NN) (PP of/IN (NP-COOD both/CC (NP p16/NN) and/CC (NP p15/NN)))) or/CC (NP (NP amplification/NN) (PP of/IN (NP CDK4/NN))))) ./.)
(S (NP-SBJ (NP Analysis/NN) (PP of/IN (NP (NP the/DT molecular/JJ differences/NNS) (PP between/IN (NP-COOD (NP primary/JJ anaplastic/JJ astrocytomas\/glioblastomas/NNS) and/CC (NP their/PRP$ subsequent/JJ recurrences/NNS))) ,/, (SBAR (WHNP-42 which/WDT) (S (NP-SBJ *T*-42/-NONE-) (VP are/VBP (ADVP clinically/RB) (ADJP-PRD indistinguishable/JJ)))) ,/,))) (VP may/MD (VP provide/VB (NP (NP better/JJR therapeutic/JJ options/NNS) (PP for/IN (NP treatment/NN))))) ./.)
